Literature DB >> 19811237

Premature menopause increases cardiovascular risk.

D F Archer1.   

Abstract

Premature menopause and bilateral oophorectomy in young women are associated with an increased incidence of cardiovascular disease, myocardial infarction and overall mortality. Observational studies suggest an interval of 5-10 years between loss of ovarian function and the increased risk of cardiovascular disease. This finding is consonant with a published autopsy study of women who had undergone bilateral oophorectomy. The progression of atherosclerosis is retarded with the use of estrogen replacement therapy in non-human primates and women. Hormone therapy reduced the incidence of cardiovascular disease in women following bilateral oophorectomy. These findings support the use of hormone therapy in young women who have lost ovarian function.

Entities:  

Mesh:

Year:  2009        PMID: 19811237     DOI: 10.1080/13697130903013452

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  15 in total

1.  Premature menopause in young breast cancer: effects on quality of life and treatment interventions.

Authors:  Shoshana M Rosenberg; Ann H Partridge
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 2.  The effects of oestrogens and their receptors on cardiometabolic health.

Authors:  Eugenia Morselli; Roberta S Santos; Alfredo Criollo; Michael D Nelson; Biff F Palmer; Deborah J Clegg
Journal:  Nat Rev Endocrinol       Date:  2017-03-17       Impact factor: 43.330

3.  Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.

Authors:  Mette Seland; Trine Bjøro; Torbjørn Furre; Thomas Schreiner; Jens Bollerslev; Sophie Dorothea Fosså; Jon Håvard Loge; Harald Holte; Cecilie Essholt Kiserud
Journal:  J Cancer Surviv       Date:  2015-03-07       Impact factor: 4.442

4.  Implications of early menopause in women exposed to perfluorocarbons.

Authors:  Sarah S Knox; Timothy Jackson; Beth Javins; Stephanie J Frisbee; Anoop Shankar; Alan M Ducatman
Journal:  J Clin Endocrinol Metab       Date:  2011-03-16       Impact factor: 5.958

Review 5.  Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Authors:  Shannon D Sullivan; Philip M Sarrel; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-12       Impact factor: 7.329

Review 6.  Per- and poly-fluoroalkyl substances (PFAS) and female reproductive outcomes: PFAS elimination, endocrine-mediated effects, and disease.

Authors:  Brittany P Rickard; Imran Rizvi; Suzanne E Fenton
Journal:  Toxicology       Date:  2021-11-10       Impact factor: 4.571

7.  Breast cancer survivorship symptom management: current perspective and future development.

Authors:  G van Londen; Eb Beckjord; Ma Dew; P Cuijpers; S Tadic; A Brufsky
Journal:  Breast Cancer Manag       Date:  2013-01

8.  Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials.

Authors:  Marianne Canonico; Geneviève Plu-Bureau; Mary Jo O'Sullivan; Marcia L Stefanick; Barbara Cochrane; Pierre-Yves Scarabin; Joann E Manson
Journal:  Menopause       Date:  2014-03       Impact factor: 2.953

Review 9.  Sex hormone therapy and progression of cardiovascular disease in menopausal women.

Authors:  Rabe E Alhurani; C Anwar A Chahal; Ahmed T Ahmed; Essa A Mohamed; Virginia M Miller
Journal:  Clin Sci (Lond)       Date:  2016-07-01       Impact factor: 6.124

Review 10.  Premature ovarian insufficiency: pathogenesis and therapeutic potential of mesenchymal stem cell.

Authors:  Akimasa Takahashi; Abdelrahman Yousif; Linda Hong; IIana Chefetz
Journal:  J Mol Med (Berl)       Date:  2021-02-27       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.